Case report: Ruxolitinib plus dexamethasone as first-line therapy in haemophagocytic lymphohistiocytosis

Haemophagocytic lymphohistiocytosis (HLH) is a cytokine-driven inflammatory syndrome caused by uncontrolled hypersecretion of inflammatory cytokines. Conventional first-line treatment for HLH included HLH-94 and HLH-2004 regimens. However, quite a few patients do not respond to treatment or cannot t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Lin, Yang, Hui, Qu, Wei-ying, Lu, Ying-jia, Feng, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029757/
https://www.ncbi.nlm.nih.gov/pubmed/36959780
http://dx.doi.org/10.3389/fonc.2023.1054175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029757/
https://www.ncbi.nlm.nih.gov/pubmed/36959780
http://dx.doi.org/10.3389/fonc.2023.1054175

Ejemplares similares